vs
Side-by-side financial comparison of FULTON FINANCIAL CORP (FULT) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $336.2M, roughly 1.5× FULTON FINANCIAL CORP). FULTON FINANCIAL CORP runs the higher net margin — 28.2% vs 6.8%, a 21.4% gap on every dollar of revenue. On growth, FULTON FINANCIAL CORP posted the faster year-over-year revenue change (4.2% vs -1.7%). Over the past eight quarters, FULTON FINANCIAL CORP's revenue compounded faster (0.2% CAGR vs -0.1%).
Fulton Financial Corporation is an American regional financial services holding company, headquartered in Lancaster, Pennsylvania.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
FULT vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $336.2M | $493.8M |
| Net Profit | $94.8M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | — | 9.9% |
| Net Margin | 28.2% | 6.8% |
| Revenue YoY | 4.2% | -1.7% |
| Net Profit YoY | 1.9% | 10.5% |
| EPS (diluted) | $0.55 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.2M | — | ||
| Q4 25 | $336.0M | $493.8M | ||
| Q3 25 | $334.6M | $492.9M | ||
| Q2 25 | $324.1M | $468.8M | ||
| Q1 25 | $318.4M | $458.4M | ||
| Q4 24 | $319.6M | $502.4M | ||
| Q3 24 | $317.7M | $511.2M | ||
| Q2 24 | $334.7M | $504.3M |
| Q1 26 | $94.8M | — | ||
| Q4 25 | $99.0M | $33.7M | ||
| Q3 25 | $100.5M | $71.7M | ||
| Q2 25 | $99.2M | $39.3M | ||
| Q1 25 | $93.0M | $20.7M | ||
| Q4 24 | $68.6M | $30.5M | ||
| Q3 24 | $63.2M | $19.4M | ||
| Q2 24 | $95.0M | $-153.0M |
| Q1 26 | — | — | ||
| Q4 25 | 35.7% | 9.9% | ||
| Q3 25 | 38.2% | 13.8% | ||
| Q2 25 | 37.8% | 12.8% | ||
| Q1 25 | 36.1% | 7.0% | ||
| Q4 24 | 27.0% | 7.8% | ||
| Q3 24 | 25.1% | 6.6% | ||
| Q2 24 | 30.8% | -31.3% |
| Q1 26 | 28.2% | — | ||
| Q4 25 | 29.5% | 6.8% | ||
| Q3 25 | 30.0% | 14.5% | ||
| Q2 25 | 30.6% | 8.4% | ||
| Q1 25 | 29.2% | 4.5% | ||
| Q4 24 | 21.5% | 6.1% | ||
| Q3 24 | 19.9% | 3.8% | ||
| Q2 24 | 28.4% | -30.3% |
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.53 | $0.40 | ||
| Q3 25 | $0.53 | $0.84 | ||
| Q2 25 | $0.53 | $0.46 | ||
| Q1 25 | $0.49 | $0.24 | ||
| Q4 24 | $0.36 | $0.37 | ||
| Q3 24 | $0.33 | $0.23 | ||
| Q2 24 | $0.52 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $3.5B | $865.9M |
| Total Assets | $32.2B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.5B | $865.9M | ||
| Q3 25 | $3.4B | $890.7M | ||
| Q2 25 | $3.3B | $833.8M | ||
| Q1 25 | $3.3B | $789.2M | ||
| Q4 24 | $3.2B | $764.9M | ||
| Q3 24 | $3.2B | $732.5M | ||
| Q2 24 | $3.1B | $706.5M |
| Q1 26 | $32.2B | — | ||
| Q4 25 | $32.1B | $2.2B | ||
| Q3 25 | $32.0B | $2.2B | ||
| Q2 25 | $32.0B | $2.1B | ||
| Q1 25 | $32.1B | $2.0B | ||
| Q4 24 | $32.1B | $2.2B | ||
| Q3 24 | $32.2B | $2.1B | ||
| Q2 24 | $31.8B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $304.5M | $114.1M | ||
| Q3 25 | $116.1M | $137.3M | ||
| Q2 25 | $91.7M | $137.2M | ||
| Q1 25 | $703.0K | $-117.5M | ||
| Q4 24 | $416.6M | $133.0M | ||
| Q3 24 | $-22.0M | $91.8M | ||
| Q2 24 | $157.8M | $107.0M |
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | 3.39× | ||
| Q3 25 | 1.16× | 1.91× | ||
| Q2 25 | 0.92× | 3.49× | ||
| Q1 25 | 0.01× | -5.66× | ||
| Q4 24 | 6.07× | 4.36× | ||
| Q3 24 | -0.35× | 4.72× | ||
| Q2 24 | 1.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FULT
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
